Generics — Net Sales
Viatris Generics — Net Sales decreased by 12.5% to $1.18B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 4.5%, from $1.13B to $1.18B. Over 4 years (FY 2021 to FY 2025), Generics — Net Sales shows a downward trend with a -7.7% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates successful product launches, higher volume, or effective pricing strategies, while a decrease may signal increased competition, patent cliffs, or pricing pressure.
Detailed definition
This metric represents the total revenue generated from the sale of generic pharmaceutical products, including both comm...
Peer comparison
Peers in the generic pharmaceutical industry typically report this as 'Generics Revenue' or 'Generic Pharmaceuticals Net Sales'.
vtrs_segment_generics_net_salesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.53B | $1.39B | $2.71B | $1.23B | $1.27B | $1.21B | $2.62B | $1.30B | $1.46B | $1.40B | $1.42B | $1.34B | $1.42B | $1.38B | $1.35B | $1.13B | $1.28B | $1.31B | $1.34B | $1.18B |
| QoQ Change | — | -9.3% | +95.8% | -54.5% | +2.8% | -4.8% | +117.2% | -50.4% | +12.8% | -4.4% | +1.6% | -5.6% | +5.8% | -3.3% | -1.9% | -16.5% | +14.0% | +2.0% | +2.6% | -12.5% |
| YoY Change | — | — | — | — | -17.0% | -12.9% | -3.4% | +5.3% | +15.6% | +16.1% | -45.7% | +3.5% | -2.9% | -1.8% | -5.2% | -16.2% | -9.7% | -4.7% | -0.3% | +4.5% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Viatris's generics — net sales?
- Viatris (VTRS) reported generics — net sales of $1.18B in Q1 2026.
- How has Viatris's generics — net sales changed year-over-year?
- Viatris's generics — net sales increased by 4.5% year-over-year, from $1.13B to $1.18B.
- What is the long-term trend for Viatris's generics — net sales?
- Over 4 years (2021 to 2025), Viatris's generics — net sales has grown at a -7.7% compound annual growth rate (CAGR), from $6.97B to $5.07B.
- What does generics — net sales mean?
- The total revenue earned from selling generic pharmaceutical products.